Cerebral dopamine neurotrophic factor and its functional fragments induce calcium signal through sigma-1 receptor and protect neurons against glutamate-induced excitotoxicity

Read full text
Authors: Nafisa Komilova, Noemí Esteras, Alessandra Preziuso, Lauren Elizabeth Millichap, Aušra Domanska, Anastasia Ludwig, Natalia Kulesskaya, Henri J. Huttunen, Kira M. Holmström, Andrey Y. Abramov, Plamena R. Angelova
Cited by: 0
References: 36

Abstract

Cerebral Dopamine Neurotrophic Factor (CDNF) is known to protect neurons in various pathologies. HER-096 is a CDNF-derived brain-penetrating peptidomimetic which also possesses neuroprotective properties. However, the mechanism underlying the cytoprotective effects is not fully understood. Using primary cortical co-culture of neurons and astrocytes we have found that both CDNF and HER-096 can induce intracellular calcium signals predominantly in astrocytes by release of Ca 2 + from endoplasmic reticulum to cytosol. This decrease in the ER Ca 2+ pool activates store-operated calcium entrance (SOCE). Initial Ca 2+ signal in these cells could be inhibited by the sigma-1 receptor antagonist BD-1047. CDNF and HER-096 reduced the glutamate-induced delayed Ca 2+ deregulation and mitochondrial depolarisation which leads to significant protection against glutamate-induced excitotoxicity. Thus, the CDNF and HER-096 sigma-1 receptor mediated Ca 2+ signal in astrocytes and neurons, from the ER, could modify the effects of high concentrations of glutamate that lead to neuroprotection. • Both CDNF and HER-096 can induce intracellular calcium signals predominantly in astrocytes by ER Ca 2+ release to cytosol. • This decrease in the ER Ca 2+ pool activates store-operated calcium entrance (SOCE). • Initial Ca 2+ signal induced by CDNF and HER-096 is sigma-1-receptor-mediated. • CDNF and HER-096 exhibit protection against glutamate-induced excitotoxicity in neurons.

Fields of Study & Subjects

Pharmacological Receptor Mechanisms and Effects Ion Channels and Receptors Endoplasmic Reticulum Stress and Disease

Publication details

Journal / source
Biomedicine & Pharmacotherapy
Volume
195
Pages
119034–119034
Publication date
27 January 2026
Language
EN